Sign inJoin waitlistJoin the waitlist

Robert Wolff

Professor of · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Hematology and Medical Oncology
Duke University Hospital
1989–1992
Internal Medicine
Duke University Hospital
1986–1989
Albany Medical College
1982–1986

Research

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials…
Journal of Clinical Oncology · 2007 · 3,093 citations
Pancreatic cancer
Review · The Lancet · 2004 · 1,673 citations
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,081 citations

GV
Gauri Varadhachary
101 papers
Matthew Katz
91 papers · 3 as a fellow
Michael Overman
91 papers · 7 as a fellow
James Abbruzzese
88 papers
Christopher Crane
87 papers
Jeffrey Lee
85 papers
Huamin Wang
70 papers
Douglas Evans
65 papers
Jean-Nicolas Vauthey
61 papers
Jason Fleming
55 papers
Milind Javle
53 papers
Scott Kopetz
50 papers

Grants

The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
National Cancer Institute · U10
Contact PI · $1.9M · University of Tx Md Anderson Can Ctr
1996–2015
Ceramide as an Intracellular Mediator
National Cancer Institute · K11
Contact PI · $235.8K · Duke University
1992–1997

Clinical trials

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
Principal investigator · Unknown
M.D. Anderson Cancer Center
2011–2021
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
Study chair · Completed · Phase 2
M.D. Anderson Cancer Center
2004–2009